Possible 先駆け審査指定制度対象品目の募集 against 大日本住友製薬 株式会社
For developers: integration details
You do not need this for normal browsing. Use it when integrating this enforcement record into an internal tool or AI workflow.
/api/v1/enforcements?company=%E5%A4%A7%E6%97%A5%E6%9C%AC%E4%BD%8F%E5%8F%8B%E8%A3%BD%E8%96%AC%20%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE&limit=10Action summary
- Company
- 大日本住友製薬 株式会社Japanese originalOriginal: 大日本住友製薬 株式会社
- Entity match
- Possible entity match60/100Machine extractedCompany name extracted from the Japanese public disclosure
- Governing law
- 薬事法薬事法
- Action type
- 先駆け審査指定制度対象品目の募集先駆け審査指定制度対象品目の募集
- Action date
- 5 October 2017
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Unapproved Parkinson's disease treatment using non-self iPS cell-derived dopamine neural precursor cells
Show original Japanese text
非自己iPS細胞由来ドパミン神経前駆細胞 パーキンソン病
Compliance context
Context neededThis is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Japanese regulatory disclosure under 薬事法.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-04-24T23:38:31.066+00:00
- Evidence checked
- 2026-04-24T23:38:31.066+00:00
- Archive captured
- 2026-04-03T10:22:00.184+00:00
Show audit JSON
{
"record": {
"id": "0ad675eb-1ab8-4608-821c-ec979b190fa8",
"url": "https://regbase.jp/en/enforcement/other-da-ri-ben-zhu-you-zhi-yao-20171005",
"company_name_original": "大日本住友製薬 株式会社",
"company_name_registry": "大日本住友製薬 株式会社",
"corporate_number": null,
"law": {
"ja": "薬事法",
"en": "薬事法"
},
"action_type": {
"ja": "先駆け審査指定制度対象品目の募集",
"en": "先駆け審査指定制度対象品目の募集"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "possible",
"confidence": 60,
"method": "extracted_japanese_name",
"method_label": "Company name extracted from the Japanese public disclosure",
"notes": null
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Context needed",
"actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
"practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
"lawContext": "Japanese regulatory disclosure under 薬事法."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-da-ri-ben-zhu-you-zhi-yao-20171005",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000179802.html",
"archiveUrl": "https://kiroku.today/view/ceb343f564ir7hxe",
"archiveCapturedAt": "2026-04-03T10:22:00.184+00:00",
"extractedAt": "2026-04-24T23:38:31.066+00:00",
"translatedAt": "2026-05-01T06:52:29.101+00:00",
"evidenceCheckedAt": "2026-04-24T23:38:31.066+00:00",
"generatedAt": "2026-06-19T10:43:33.768Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)Company info
- English name
- 大日本住友製薬 株式会社 Japanese original
- Japanese name
- 大日本住友製薬 株式会社
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.